KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Cash from Investing Activities (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Cash from Investing Activities for 8 consecutive years, with -$8.3 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 137.31% to -$8.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.9 million through Dec 2025, down 51.22% year-over-year, with the annual reading at $37.9 million for FY2025, 51.22% down from the prior year.
  • Cash from Investing Activities hit -$8.3 million in Q4 2025 for Adaptive Biotechnologies, down from $17.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $93.8 million in Q1 2021 to a low of -$97.5 million in Q4 2022.
  • Historically, Cash from Investing Activities has averaged $21.5 million across 5 years, with a median of $23.8 million in 2024.
  • Biggest five-year swings in Cash from Investing Activities: crashed 245.13% in 2022 and later soared 686.41% in 2023.
  • Year by year, Cash from Investing Activities stood at $67.2 million in 2021, then plummeted by 245.13% to -$97.5 million in 2022, then soared by 103.29% to $3.2 million in 2023, then surged by 589.71% to $22.1 million in 2024, then crashed by 137.31% to -$8.3 million in 2025.
  • Business Quant data shows Cash from Investing Activities for ADPT at -$8.3 million in Q4 2025, $17.3 million in Q3 2025, and $3.3 million in Q2 2025.